Biofrontera Inc. — Investor Relations & Filings
Filings indexed
351
across all filing types
Latest filing
2026-05-14
Regulatory Filings
Country
US
United States of America
Listing
US
BFRI
Biofrontera Inc. is a biopharmaceutical company that commercializes a portfolio of pharmaceutical products for the treatment of dermatological conditions. The company specializes in photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used to treat actinic keratoses, a type of pre-cancerous skin lesion, and impetigo, a bacterial skin infection. Biofrontera focuses on establishing PDT as a standard of care in dermatology and utilizes a proprietary nanoemulsion technology to improve the stability and skin penetration of its formulations, potentially increasing clinical efficacy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45988883 | 8-K | 2026-05-14 | English | ||
| 32989302 | 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32986713 | 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32911294 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911293 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911292 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911288 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911287 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911284 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911281 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32899942 | 8-K - BIOFRONTERA INC. (0001858685) (Filer) | 2026-02-26 | English | ||
| 32100293 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 32100370 | 8-K Filing | 2026-02-09 | English | ||
| 32100337 | SCHEDULE 13G/A Filing | 2026-01-28 | English | ||
| 13442747 | 8-K | 2026-01-13 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ishita Drugs & Industries Ltd.
Produces APIs, drug intermediates, and folic acid for globa…
|
524400 | IN | Manufacturing |
|
Isodiol International Inc.
Develops and distributes hemp-based consumer goods and high…
|
ISOLF | CA | Manufacturing |
|
IsoTis S.A.
Specialized in proprietary orthobiologics products for the …
|
ISON | CA | Manufacturing |
|
ISU Abxis Co., Ltd.
Develops antibody-based immunotherapies for oncology and ra…
|
086890 | KR | Manufacturing |
|
Iterum Therapeutics plc
Develops and commercializes anti-infectives for multi-drug …
|
ITRM | US | Manufacturing |
|
IX BIOPHARMA LTD.
A specialty pharmaceutical and nutraceutical company develo…
|
42C | SG | Manufacturing |
|
Jacobio Pharmaceuticals Group Co., Ltd.
Biopharma specializing in innovative oncology therapies dis…
|
1167 | KY | Manufacturing |
|
Jacobson Pharma Corporation Limited
Leading regional pharmaceutical group specializing in the p…
|
2633 | HK | Manufacturing |
|
Jagsonpal Pharmaceuticals Limited
Develops and markets formulations for gynecology, orthopedi…
|
JAGSNPHARM | IN | Manufacturing |
|
Jaguar Health, Inc.
Develops plant-based prescription medicines for human and a…
|
JAGX | US | Manufacturing |
Biofrontera Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35198/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35198 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35198 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35198 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35198}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biofrontera Inc. (id: 35198)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.